News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By BBC, BBC | 06.21.2008

A report by the UK charity says increasing numbers of female foetuses were being aborted and baby girls deliberately neglected...

By Clive Cookson, Financial Times | 06.20.2008

Scientists at Newcastle University in the UK have already produced almost 300 hybrid embryos, by inserting human DNA into cow...

By Deborah Smith, The Sydney Morning Herald | 06.20.2008
SYDNEY scientists are confident they will be the first in the world to create cloned human embryos after the announcement...
By Press Trust of India, Press Trust of India | 06.19.2008

In the first case of its kind, doctors have treated a cancer patient by injecting him with billions of his...

By Brisbane Times, Brisbane Times | 06.19.2008

New Zealand parents involved in IVF programs could soon be allowed to choose the sex of their child if the...

By Bernadette Tansey, San Francisco Chronicle | 06.17.2008
The veteran Silicon Valley venture capital firm that helped found the biotechnology industry, Kleiner Perkins Caufield & Byers, is now...
Press Statement

Hearing on "Genetics and other Human Modification Technologies" will be webcast

Richard Hayes, the executive director of the Center for Genetics and Society, will testify before the US House Foreign Affairs Committee Subcommittee on Terrorism, Nonproliferation and Trade on Thursday June 19. The subcommittee, chaired by Rep. Brad Sherman (D-Los Angeles), will hold a hearing on "Genetics and other Human Modification Technologies: Sensible International Regulation or a New Kind of Arms Race."

"Genetics and other Human Modification Technologies: Sensible International Regulation or a New Kind of Arms Race"
Hearing of House Subcommittee on Terrorism, Nonproliferation and Trade
Thursday June 19 at 10 AM
2200 Rayburn House Office Building
webcast at the subcommittee's website

Speakers will include:

  • Richard Hayes, Ph.D., Executive Director, Center for Genetics and Society
  • Jamie F. Metzl, Ph.D, Executive Vice President, Asia Society
  • Paul R. Billings M.D., Ph.D., President and Chief Executive Officer, Cellpoint Diagnostics, Inc.
  • Nigel M. de S. Cameron, Ph.D., President and Co-founder, Institute on Biotechnology and the Human Future

Topics will include:

  • the social challenges posed by human biotechnologies
  • the threat of genetically modified bioweapons
  • the state of international policy regulating these technologies
  • the shape of possible global regulatory agreements.

Dr. Hayes will address the question, "Is There an Emerging International Consensus on the Proper Uses of the New Human Genetic Technologies?" His prepared testimony is available [PDF] at the Center's website.

The hearing is scheduled for 10:00 a.m. in 2200 Rayburn House Office Building, and will be webcast. For more information, see the subcommittee's website.

The Center for Genetics and Society is a public affairs and policy advocacy organization working to encourage responsible uses and effective societal governance of human biotechnologies.


Contact:
Jesse Reynolds
jreynolds[AT]geneticsandsociety[DOT]org
1-510-625-0819 x308

Richard Hayes
rhayes[AT]geneticsandsociety[DOT]org
1-510-332-1769


 

By Marcus Wohlsen, San Francisco Chronicle | 06.16.2008
California health regulators have demanded that 13 direct-to-consumer genetic testing startups halt sales in the state until they prove they...